SVFYX | VIVIX | SVFYX / VIVIX | |
Total Expense Ratio | 0.82 | 0.04 | 2,050% |
Annual Report Gross Expense Ratio | 0.82 | 0.04 | 2,050% |
Fund Existence | 10 years | 27 years | - |
Gain YTD | -14.625 | -4.290 | 341% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000000 | 5000000 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.46B | 191B | 2% |
Annual Yield % from dividends | 1.53 | 2.27 | 67% |
Returns for 1 year | -17.16 | 2.23 | -770% |
Returns for 3 years | 1.99 | 9.75 | 20% |
Returns for 5 years | 85.51 | 66.77 | 128% |
Returns for 10 years | 83.43 | 91.47 | 91% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HFYTX | 10.47 | 0.27 | +2.65% |
Hartford Schroders Intl Multi-Cp Val R5 | |||
PRHSX | 75.45 | 1.78 | +2.42% |
T. Rowe Price Health Sciences | |||
SEWIX | 15.42 | 0.26 | +1.72% |
NAA World Equity Income Instl | |||
EPSRX | 21.00 | 0.35 | +1.69% |
NYLI Epoch Global Equity Yield Class R6 | |||
KSDVX | 14.36 | 0.18 | +1.27% |
Keeley Small Cap Dividend Value A |